1. The balloon spacer improves outcomes in only a minority of patients with an irreparable rotator cuff tear
- Author
-
Malin D. Wijeratna, Eshan N.H. Oderuth, John M. Geoghegan, Paul Manning, Ben W. Gooding, and Daniel L.J. Morris
- Subjects
030222 orthopedics ,medicine.medical_specialty ,business.industry ,Mean age ,030229 sport sciences ,Balloon ,Medium term ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Medicine ,Tears ,Orthopedics and Sports Medicine ,Rotator cuff ,Reverse total shoulder replacement ,business - Abstract
Background We report our medium-term outcomes of the balloon spacer in treating irreparable massive rotator cuff tears (MRCT). Methods Twenty-two patients (17 male:5 female; mean age 68.2 years) had a balloon spacer arthroscopically inserted between September 2013–May 2017 after failing non-surgical management or rotator cuff repair. Oxford Shoulder Scores (OSS) were collected prospectively at baseline and prior to reverse total shoulder replacement (rTSR) or at most recent follow up for those with the balloon spacer still in-situ. Results A significant OSS improvement at mean follow-up 31.4 months (5–63) was found analysing all patients who had a balloon inserted (23.6 vs 29.6; p Conclusion The balloon spacer is effective in a minority of patients in the medium term. The majority either convert to rTSR or remain symptomatic with the risk of failure higher in those who are older with a low baseline OSS.
- Published
- 2021